LD-2 disclosure · 2nd Quarter - Report
ROCHE DIAGNOSTICS CORPORATION
via HOOPER, LUNDY & BOOKMAN, P.C.
Client
- Description
- Healthcare
- Location
- Indiana · United States of America
Registrant
- Firm
- HOOPER, LUNDY & BOOKMAN, P.C.
- Description
- law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Issues related to clinical diagnostic laboratory services; Issues related to public health emergency preparedness; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
LobbyistsLISA LAYMAN
Covered position (LISA LAYMAN): SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medical/Disease Research/Clinical Labs
H.R. 2369 The Verifying Leading-edge IVCT Development Act.
LobbyistsLISA LAYMAN
Covered position (LISA LAYMAN): SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
S.1000 / H.R. 1835 Saving Access to Laboratory Services Act (SALSA).
LobbyistsLISA LAYMAN